-
Clovis Oncology (CLVS) PT Slashed 74% to $19 at RBC Capital
-
Pre-Open Movers 10/19: (AVXL) (PYPL) (PG) Higher; (MACK) (OZK) (AKTS) Lower (more...)
-
Clovis Oncology (CLVS) Could Trade Up $8-$16 on TRITON2 44% ORR - RBC
-
Clovis Oncology (CLVS) PT Lowered to $73 at RBC Capital
-
Clovis Oncology (CLVS) PT Raised to $74 at RBC Capital
-
RBC Capital Upgrades Clovis Oncology (CLVS) to Outperform
-
RBC Capital Starts Clovis Oncology (CLVS) at Sector Perform
-
Notable Analyst Rating Changes 10/25: (MKC) (FE) (CHK) Upgraded; (VFC) (ARIA) (OCN) Downgraded
-
Buy Immunogen (IMGN) on Clovis-Related Sell-Off, RBC Capital Says